On the public citation graph

Plasma HIV-2 RNA According to CD4 Count Strata among HIV-2-Infected Adults in the IeDEA West Africa Collaboration

https://doi.org/10.1371/journal.pone.0129886
0 signed · 57 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

Is this your work? Sign in with ORCID and put your name on the claims that are yours.
Claim with ORCID
Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.
See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1002/jmv.20174openalex-snapshot
High frequency of selection of K65R and Q151M mutations in HIV‐2 infected patients receiving nucleoside reverse transcriptase inhibitors containing regimen
inferredcites →https://doi.org/10.1016/j.jcv.2012.06.024openalex-snapshot
Validation for clinical use of a novel HIV-2 plasma RNA viral load assay using the Abbott m2000 platform
inferredcites →https://doi.org/10.1016/j.jcv.2013.08.003openalex-snapshot
Highly sensitive plasma RNA quantification by real-time PCR in HIV-2 group A and group B infection
inferredcites →https://doi.org/10.1016/j.jcv.2013.09.007openalex-snapshot
Validation and clinical use of a sensitive HIV-2 viral load assay that uses a whole virus internal control
inferredcites →https://doi.org/10.1016/j.jviromet.2006.02.005openalex-snapshot
Development and evaluation of a real-time RT-PCR assay for quantification of cell-free human immunodeficiency virus type 2 using a Brome Mosaic Virus internal control
inferredcites →https://doi.org/10.1016/s0140-6736(94)90065-5openalex-snapshot
Slower heterosexual spread of HIV-2 than HIV-1
inferredcites →https://doi.org/10.1053/jinf.2001.0792openalex-snapshot
Antiretroviral Therapy for HIV-2 Infected Patients
inferredcites →https://doi.org/10.1056/nejmoa1105243openalex-snapshot
Prevention of HIV-1 Infection with Early Antiretroviral Therapy
inferredcites →https://doi.org/10.1086/596504openalex-snapshot
Emergence of Multiclass Drug–Resistance in HIV‐2 in Antiretroviral‐Treated Individuals in Senegal: Implications for HIV‐2 Treatment in Resouce‐Limited West Africa
inferredcites →https://doi.org/10.1086/656284openalex-snapshot
Mother‐to‐Child Transmission of HIV‐2 Infection from 1986 to 2007 in the ANRS French Perinatal Cohort EPF‐CO1
inferredcites →https://doi.org/10.1089/088922201750290050openalex-snapshot
Synthetic Peptide Strategy for the Detection of and Discrimination among Highly Divergent Primate Lentiviruses
inferredcites →https://doi.org/10.1093/cid/ciq248openalex-snapshot
Update on Human Immunodeficiency Virus (HIV)-2 Infection
inferredcites →https://doi.org/10.1093/ije/dyr080openalex-snapshot
Cohort Profile: The international epidemiological databases to evaluate AIDS (IeDEA) in sub-Saharan Africa
inferredcites →https://doi.org/10.1093/jac/dks363openalex-snapshot
Mutations selected in HIV-2-infected patients failing a regimen including atazanavir
inferredcites →https://doi.org/10.1097/00002030-200209060-00010openalex-snapshot
Mortality of HIV-1, HIV-2 and HIV-1/HIV-2 dually infected patients in a clinic-based cohort in The Gambia
inferredcites →https://doi.org/10.1097/01.aids.0000199829.57112.2fopenalex-snapshot
CD4 cell recovery in treated HIV-2-infected adults is lower than expected: results from the French ANRS CO5 HIV-2 cohort
inferredcites →https://doi.org/10.1097/01.aids.0000432443.22684.50openalex-snapshot
Evidence for continuing cross-species transmission of SIVsmm to humans
inferredcites →https://doi.org/10.1097/qad.0b013e3282f4ddfcopenalex-snapshot
Comparison of viro-immunological marker changes between HIV-1 and HIV-2-infected patients in France
inferredcites →https://doi.org/10.1097/qad.0b013e3283377a06openalex-snapshot
First-year lymphocyte T CD4+ response to antiretroviral therapy according to the HIV type in the IeDEA West Africa collaboration
inferredcites →https://doi.org/10.1111/j.1747-0285.2008.00647.xopenalex-snapshot
Inhibition of HIV‐2 Protease by HIV‐1 Protease Inhibitors in Clinical Use
inferredcites →https://doi.org/10.1128/aac.01284-07openalex-snapshot
In Vitro Phenotypic Susceptibility of Human Immunodeficiency Virus Type 2 Clinical Isolates to Protease Inhibitors
inferredcites →https://doi.org/10.1128/jcm.00724-14openalex-snapshot
New Sensitive One-Step Real-Time Duplex PCR Method for Group A and B HIV-2 RNA Load
inferredcites →https://doi.org/10.1128/jcm.02389-10openalex-snapshot
An International Collaboration To Standardize HIV-2 Viral Load Assays: Results from the 2009 ACHI E V 2E Quality Control Study
inferredcites →https://doi.org/10.1128/jcm.43.8.4234-4236.2005openalex-snapshot
Improved Sensitivity of Human Immunodeficiency Virus Type 2 Subtype B Plasma Viral Load Assay
inferredcites →https://doi.org/10.1155/2011/463704openalex-snapshot
Antiretroviral Therapy for HIV-2 Infection: Recommendations for Management in Low-Resource Settings
inferredcites →https://doi.org/10.1177/135965350400900422openalex-snapshot
Selection of K65R Mutation in HIV-2-Infected Patients Receiving Tenofovir-Containing Regimen
inferredcites →https://doi.org/10.1186/1471-2334-14-461openalex-snapshot
Antiretroviral therapy response among HIV-2 infected patients: a systematic review
inferredcites →https://doi.org/10.1371/journal.pone.0066135openalex-snapshot
Characteristics of HIV-2 and HIV-1/HIV-2 Dually Seropositive Adults in West Africa Presenting for Care and Antiretroviral Therapy: The IeDEA-West Africa HIV-2 Cohort Study
inferredcites →https://doi.org/10.7448/ias.17.1.19064openalex-snapshot
Re‐testing and misclassification of HIV‐2 and HIV‐1&2 dually reactive patients among the HIV‐2 cohort of The West African Database to evaluate AIDS collaboration
inferredcites →https://doi.org/10.7448/ias.18.1.19380openalex-snapshot
Response to “Rapid tests for HIV type discrimination in West Africa may perform differently”

What points at this work

Incoming claims: where this work appears in other papers’ reference lists and arguments.

inferred← citeshttps://doi.org/10.2139/ssrn.4605784openalex-extracted
Efficacy and Safety of Three Antiretroviral Therapy Regimens in Treatment-Naive African Adults Infected with HIV-2: A Randomised Controlled Phase II Trial
inferred← citeshttps://doi.org/10.1016/b978-0-323-82763-8.00209-0openalex-snapshot
Oncoviruses (Human T-Cell Lymphotropic Viruses) and Lentiviruses (Human Immunodeficiency Virus Type 2)
inferred← citeshttps://doi.org/10.1016/j.diagmicrobio.2025.117222openalex-snapshot
Expression profiles of GPR56 and CD99 in T cells of AIDS patients and assessment of diagnostic value
inferred← citeshttps://doi.org/10.1016/j.jcv.2016.11.011openalex-snapshot
Clinical validation of a novel diagnostic HIV-2 total nucleic acid qualitative assay using the Abbott m2000 platform: Implications for complementary HIV-2 nucleic acid testing for the CDC 4th generation HIV diagnostic testing algorithm
inferred← citeshttps://doi.org/10.1016/j.jiph.2021.03.009openalex-snapshot
Quantitative proteomics analysis reveals unique but overlapping protein signatures in HIV infections
inferred← citeshttps://doi.org/10.1016/j.jviromet.2019.03.005openalex-snapshot
Performance of Bio-Rad HIV-1/2 Confirmatory Assay in HIV-1, HIV-2 and HIV-1/2 dually reactive patients - comparison with INNO-LIA and immunocomb discriminatory assays
inferred← citeshttps://doi.org/10.1016/j.meegid.2016.08.010openalex-snapshot
Hiv-2 molecular epidemiology
inferred← citeshttps://doi.org/10.1016/s2352-3018(18)30094-8openalex-snapshot
90-90-90 for HIV-2? Ending the HIV-2 epidemic by enhancing care and clinical management of patients infected with HIV-2
inferred← citeshttps://doi.org/10.1016/s2352-3018(24)00085-7openalex-snapshot
Efficacy and safety of three antiretroviral therapy regimens for treatment-naive African adults living with HIV-2 (FIT-2): a pilot, phase 2, non-comparative, open-label, randomised controlled trial
inferred← citeshttps://doi.org/10.1093/cid/ciaa277openalex-snapshot
Long-term Experience and Outcomes of Programmatic Antiretroviral Therapy for Human Immunodeficiency Virus Type 2 Infection in Senegal, West Africa
inferred← citeshttps://doi.org/10.1093/cid/ciy245openalex-snapshot
First-line Raltegravir/Emtricitabine/Tenofovir Combination in Human Immunodeficiency Virus Type 2 (HIV-2) Infection: A Phase 2, Noncomparative Trial (ANRS 159 HIV-2)
inferred← citeshttps://doi.org/10.1093/jac/dkaa112openalex-snapshot
Effectiveness of dolutegravir-based antiretroviral treatment for HIV-2 infection: retrospective observational study from Western India
inferred← citeshttps://doi.org/10.1097/qad.0000000000001485openalex-snapshot
HIV type 2 epidemic in Spain
inferred← citeshttps://doi.org/10.1097/qad.0000000000002184openalex-snapshot
T-cell and B-cell perturbations identify distinct differences in HIV-2 compared with HIV-1-induced immunodeficiency
inferred← citeshttps://doi.org/10.1097/qad.0000000000003015openalex-snapshot
Lymphoma in HIV-2-infected patients in combination antiretroviral therapy era
inferred← citeshttps://doi.org/10.1111/hiv.13204openalex-snapshot
British HIV Association guidelines for the management of HIV‐2 2021
inferred← citeshttps://doi.org/10.1128/jcm.00235-17openalex-snapshot
Assessment of the Cavidi ExaVir Load Assay for Monitoring Plasma Viral Load in HIV-2-Infected Patients
inferred← citeshttps://doi.org/10.1128/jcm.00755-17openalex-snapshot
New Highly Sensitive Real-Time PCR Assay for HIV-2 Group A and Group B DNA Quantification
inferred← citeshttps://doi.org/10.1128/jcm.02303-20openalex-snapshot
HIV-2 Drug Resistance Genotyping from Dried Blood Spots
inferred← citeshttps://doi.org/10.11604/pamj.2019.33.222.15771openalex-snapshot
Infection à VIH-2 au Sénégal: échecs virologiques et résistances aux antirétroviraux (ARV)
inferred← citeshttps://doi.org/10.15406/jmen.2017.05.00169openalex-snapshot
Low Level of HIV-2 Replication in Patients on Long-Term Antiretroviral Therapy in Togo
inferred← citeshttps://doi.org/10.21203/rs.3.rs-2396690/v1openalex-snapshot
Impact of Persistent Organic Pollutants on AIDS Progression and All-Cause Mortality. A Longitudinal Study in HIV-2 Infected Individuals in Guinea-Bissau
inferred← citeshttps://doi.org/10.2174/1570162x20666220609155237openalex-snapshot
Can In-house HIV-2 Viral Load Assay be a Reliable Alternative to Commercial Assays for Clinical and Therapeutic Monitoring?
inferred← citeshttps://doi.org/10.3389/fimmu.2026.1825935openalex-snapshot
HIV-2 infection as a comparative lens for functional HIV-1 remission
inferred← citeshttps://doi.org/10.3390/diagnostics12112657openalex-snapshot
Recent HIV Infection: Diagnosis and Public Health Implications
inferred← citeshttps://doi.org/10.70675/f8627351ze846z41b4zbb53zfbeef2b2e76dopenalex-snapshot
Conception de nouveaux vaccins anti-VIH basés sur des épitopes conformationels cross clade de gp41 issus d'anticorps muqueux protecteurs de sujets exposés au VIH mais restant séronégatifs (ESN)
inferred← citeshttps://doi.org/10.7448/ias.17.1.19064openalex-snapshot
Re‐testing and misclassification of HIV‐2 and HIV‐1&2 dually reactive patients among the HIV‐2 cohort of The West African Database to evaluate AIDS collaboration
Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.